You are here

PwC

Industry M&A volume declined 8% this year compared to '23

Fierce Biotech

Thu, 12/12/24 - 11:43 am

Biopharma dealmaking continues to rise, but M&A values hold steady: PwC

Fierce Biotech

Thu, 06/20/24 - 11:43 am

Pharma, Life Sciences Sector to See Healthy M&A Activity in 2024: PwC

BioSpace

Thu, 12/14/23 - 09:54 am

PwC predicts 'flurry' of $5B to $15B biotech deals in 2023

Endpoints

Wed, 01/18/23 - 09:52 am

Despite 'lackluster' 2022, PwC remains 'bullish' on pharma M&A in 2023

Endpoints

Fri, 12/16/22 - 10:29 am

M&A is down, but Big Pharma likely to line up 'multiple shots on goal' in 2nd half, PwC says

Fierce Biotech

Fri, 06/24/22 - 10:25 am

PwC report sees pharma-biotech deals 'to be extremely active in 2020'

Fierce Biotech

Fri, 01/24/20 - 10:57 am

PwC Analysis: Fewer New Regulations in 2017, But No Major Course Change at FDA

RAPS.org

Thu, 02/22/18 - 11:18 pm